Cargando…

Is Melanoma Progression Affected by Thyroid Diseases?

Clinical and epidemiological evidence indicate a relationship between thyroid diseases and melanoma. In particular, the hypothyroidism condition appears to promote melanoma spread, which suggests a protective role of thyroid hormones against disease progression. In addition, experimental data sugges...

Descripción completa

Detalles Bibliográficos
Autores principales: Ulisse, Salvatore, Baldini, Enke, Pironi, Daniele, Gagliardi, Federica, Tripodi, Domenico, Lauro, Augusto, Carbotta, Sabino, Tarroni, Danilo, D’Armiento, Matteo, Morrone, Aldo, Forte, Flavio, Frattaroli, Flaminia, Persechino, Severino, Odorisio, Teresa, D’Andrea, Vito, Lori, Eleonora, Sorrenti, Salvatore
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9456309/
https://www.ncbi.nlm.nih.gov/pubmed/36077430
http://dx.doi.org/10.3390/ijms231710036
Descripción
Sumario:Clinical and epidemiological evidence indicate a relationship between thyroid diseases and melanoma. In particular, the hypothyroidism condition appears to promote melanoma spread, which suggests a protective role of thyroid hormones against disease progression. In addition, experimental data suggest that, in addition to thyroid hormones, other hormonal players of the hypothalamic–pituitary–thyroid (HPT) axis, namely the thyrotropin releasing hormone and the thyrotropin, are likely to affect melanoma cells behavior. This information warrants further clinical and experimental studies in order to build a precise pattern of action of the HPT hormones on melanoma cells. An improved knowledge of the involved molecular mechanism(s) could lead to a better and possibly personalized clinical management of these patients.